Dynarex Corporation Expands Recall To Include Additional Products Due To Possible Health Risk
| Batch No. |
Mfg. Dt. |
Exp. Dt. |
Pack Size |
| B 048 |
31.10.2023 |
30.10.2026 |
Baby Powder 14 oz. (397 g) |
| B 049 |
01.11.2023 |
31.10.2026 |
Baby Powder 14 oz. (397 g) |
| B 050 |
02.11.2023 |
01.11.2026 |
Baby Powder 14 oz. (397 g) |
| B 051 |
29.12.2023 |
28.12.2026 |
Baby Powder 14 oz. (397 g) |
| B 052 |
30.12.2023 |
29.12.2026 |
Baby Powder 14 oz. (397 g) |
| B 053 |
01.01.2024 |
31.12.2026 |
Baby Powder 4 oz. (113 g) |
| B 054 |
03.01.2024 |
02.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 055 |
04.01.2024 |
03.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 056 |
05.01.2024 |
04.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 057 |
06.01.2024 |
05.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 058 |
08.01.2024 |
07.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 059 |
31.01.2024 |
30.01.2027 |
Baby Powder 4 oz. (113 g) |
| B 060 |
01.02.2024 |
31.01.2027 |
Baby Powder 4 oz. (113 g) |
Please contact
Dynarex Corporation at 888-396-2739 or 845-365-8200 during business hours of 8:30 AM to 5:00 PM Eastern Standard Time, or via email at [email protected] if you have any questions or need information on how to return the product or receive a full refund.
Health care professionals and consumers are encouraged to report any adverse events to FDA's
MedWatch Adverse Event Reporting program by:
-
Completing and submitting the report online at
MedWatch Online Voluntary Reporting Form Downloading and completing the form, then submitting it via fax at
1-800-FDA-0178
SOURCE Dynarex Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.






Comments
No comment